Citadel Advisors - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is and the CUSIP is 452907908. A total of 2 filers reported holding IMMUNOMEDICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2016$224,000
+194.7%
96,400
+218.2%
0.00%
Q1 2016$76,000
-83.3%
30,300
-79.5%
0.00%
Q4 2015$454,000
+109.2%
147,800
+17.4%
0.00%
Q3 2015$217,000
-82.2%
125,900
-58.1%
0.00%
-100.0%
Q2 2015$1,221,000
+99.5%
300,800
+88.2%
0.00%0.0%
Q1 2015$612,000
+14.0%
159,800
+42.8%
0.00%0.0%
Q4 2014$537,000
+80.2%
111,900
+39.5%
0.00%
Q3 2014$298,000
+9.2%
80,200
+7.4%
0.00%
Q2 2014$273,000
+62.5%
74,700
+87.7%
0.00%
Q1 2014$168,000
-59.7%
39,800
-56.1%
0.00%
-100.0%
Q4 2013$417,000
+61.0%
90,700
+117.0%
0.00%
Q3 2013$259,000
-9.8%
41,800
-20.8%
0.00%
Q2 2013$287,00052,8000.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 729,400$3,968,0000.10%
Citadel Advisors 52,800$287,0000.00%
View complete list of IMMUNOMEDICS INC shareholders